SMSLIFE Stock Overview
SMS Lifesciences India Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
SMS Lifesciences India Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹674.95 |
| 52 Week High | ₹789.90 |
| 52 Week Low | ₹472.05 |
| Beta | 0.66 |
| 1 Month Change | 7.54% |
| 3 Month Change | 16.31% |
| 1 Year Change | 23.71% |
| 3 Year Change | 11.38% |
| 5 Year Change | 25.62% |
| Change since IPO | 400.52% |
Recent News & Updates
SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky
Feb 10
There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump
Jan 05Recent updates
SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky
Feb 10There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump
Jan 05Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?
Sep 23SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50
Sep 07SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50
Aug 24SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50
Sep 16SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50
Sep 02SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt
Jun 03With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting
May 13SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals
Nov 23Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?
Jun 21Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Feb 22SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Jan 04Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares
Nov 27Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?
Nov 24Shareholder Returns
| SMSLIFE | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -8.3% | -0.1% | 1.8% |
| 1Y | 23.7% | 55.9% | 46.4% |
Return vs Industry: SMSLIFE underperformed the Indian Pharmaceuticals industry which returned 55.9% over the past year.
Return vs Market: SMSLIFE underperformed the Indian Market which returned 46.4% over the past year.
Price Volatility
| SMSLIFE volatility | |
|---|---|
| SMSLIFE Average Weekly Movement | 7.7% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: SMSLIFE has not had significant price volatility in the past 3 months.
Volatility Over Time: SMSLIFE's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 567 | Talluri Veera Venkata Murthy | www.smslife.in |
SMS Lifesciences India Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers APIs in various therapeutic areas, such as antiulcer, erectile dysfunction, anti-gout, anesthesia, anti-infective, anti-obesity, antifungal, anti-convulsant, anti-emetic, ophthalmic, anti-worm, and antiemetic. It also exports its products.
SMS Lifesciences India Limited Fundamentals Summary
| SMSLIFE fundamental statistics | |
|---|---|
| Market cap | ₹2.04b |
| Earnings (TTM) | ₹48.93m |
| Revenue (TTM) | ₹2.80b |
41.7x
P/E Ratio0.7x
P/S RatioIs SMSLIFE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SMSLIFE income statement (TTM) | |
|---|---|
| Revenue | ₹2.80b |
| Cost of Revenue | ₹1.95b |
| Gross Profit | ₹848.90m |
| Other Expenses | ₹799.97m |
| Earnings | ₹48.93m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 16.19 |
| Gross Margin | 30.35% |
| Net Profit Margin | 1.75% |
| Debt/Equity Ratio | 58.0% |
How did SMSLIFE perform over the long term?
See historical performance and comparison